Last updated on April 2009

Non-Invasive Determination of Fetal Chromosome Abnormalities


Brief description of study

The overall significance of this study is to develop a laboratory developed test (LDT) to use a new marker in the maternal blood to better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (trisomy 21), Edward's syndrome (trisomy 18), Patau syndrome (trisomy 13), Klinefelter syndrome, (47, XXY), and other chromosome abnormalities. Accomplishing that task would reduce the need for invasive amniocentesis and CVS procedures.

Clinical Study Identifier: NCT00891852

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Elizabeth Kramer, GC

Maryland Perinatal Associates
Rockville, MD United States
  Connect »

Diane London, Perinatal Nurse

Atlantic Maternal Fetal Medicine
Moristown, NJ United States
  Connect »

Martin Chavez, MD

Winthrop University Hospital
Mineola, NY United States
  Connect »

Jonathan D Herman, MD

Elite Women's Health
New Hyde Park, NY United States
  Connect »

Erica Speigel, GC

Columbia University, NewYork-Presbyterian Hospital
New York, NY United States
  Connect »

Daniel Saltzman, MD

New York Perinatal Associates
New York, NY United States
  Connect »

Stephen A Brown, MD

UVM
Burlington, VT United States
  Connect »